1. Home
  2. FCF vs TRVI Comparison

FCF vs TRVI Comparison

Compare FCF & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

SELL

Current Price

$20.29

Market Cap

2.2B

Sector

Finance

ML Signal

SELL

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$11.89

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
TRVI
Founded
1934
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
FCF
TRVI
Price
$20.29
$11.89
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$24.07
★ $28.18
AVG Volume (30 Days)
1.0M
★ 2.4M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
★ 2.77%
N/A
EPS Growth
5.76
★ 31.91
EPS
★ 0.81
N/A
Revenue
N/A
N/A
Revenue This Year
$6.49
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
$24.95
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.00
$9.82
52 Week High
$22.34
$20.22

Technical Indicators

Market Signals
Indicator
FCF
TRVI
Relative Strength Index (RSI) 46.63 21.29
Support Level $19.85 $9.97
Resistance Level $20.87 $13.55
Average True Range (ATR) 0.33 0.63
MACD 0.01 -0.08
Stochastic Oscillator 67.38 8.52

Price Performance

Historical Comparison
FCF
TRVI

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: